(Q43624603)

25 November 2017

title

Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics (English)

1 reference

25 November 2017

0 references

1 reference

Cimochowski GE

1

1 reference

25 November 2017

Harostock MD

2

1 reference

25 November 2017

Brown R

3

1 reference

25 November 2017

Bernardi M

4

1 reference

25 November 2017

Alonzo N

5

1 reference

25 November 2017

Coyle K

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

The Annals of Thoracic Surgery

25 November 2017

published in

1 reference

25 November 2017

volume

71

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

1572-8; discussion 1578-9

1 reference

Factors predisposing to median sternotomy complications. Deep vs superficial infection

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The epidemiology of chest and leg wound infections following cardiothoracic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Risk factors for surgical-wound infection following cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Nasal staphylococci and sepsis in hospital patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The economic implications of infection in cardiac surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The nose: an underestimated source of Staphylococcus aureus causing wound infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Glucose control lowers the risk of wound infection in diabetics after open heart operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

10.1016/S0003-4975(01)02519-X

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference